23.7 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against S was 23.7% among males.
MaliSARS-CoV-2 S proteinHAL · Unilimdocument of 67 observations
Gold tier: mechanically validated evidence, with its primary source.
1,197 evidence items · page 21 / 48
23.7 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against S was 23.7% among males.
MaliSARS-CoV-2 S proteinHAL · Unilimdocument of 67 observations
769,770,000 infectionsBy August 2023, COVID-19 had resulted in 769.77 million infections globally.
MaliCOVID-19observed August 2023HAL · Unilimdocument of 88 observations
598 casesOfficially reported COVID-19 cases in Tombouctou were 598 as of April 2021.
MaliCOVID-19observed April 2021HAL · Unilimdocument of 88 observations
0.56 %La fréquence des co-infections Plasmodium falciparum et Plasmodium malariae était de 0,56 % dans la commune rurale de Ntjiba, Mali, entre 2016 et 2021.
MaliPlasmodium falciparum et Plasmodium malariaeobserved 2016 à 2021HAL · Unilimdocument of 214 observations
11,890 casesThe study collected data on 11,890 cases of severe malaria due to Plasmodium falciparum.
Malipaludismepublished 2014Nature geneticseurope_pmcdocument of 2 observationsDOI 10.1038/ng.3107
0.9 allele_frequencyThe Kna/b DNA polymorphism allele frequencies were Kna (V1561) 0.9 and Knb (M1561) 0.1.
Malipaludismepublished 2004TransfusionOpenAlexdocument of 3 observations
36 %Of the 300 children, 107 (36%) had at least one malaria attack.
Malipaludismepublished 2025New microbes and new infectionseurope_pmcdocument of 2 observations
48 %Plasmodium falciparum infection occurred in 36 participants (48%) in the 150-mg L9LS group.
Malipaludismepublished 2024The New England journal of medicineeurope_pmcdocument of 7 observations
0.9 %The lowest long-lasting insecticidal net (LLIN) routine distribution coverage rate (0.9%) was observed in the health district of Tin-essako (Kidal region in the north) in the year 2017–2018.
Malipaludismeobserved 2017–2018HAL · Unilimdocument of 111 observations
32 hoursThe median parasite clearance time was 32 hours.
Malipaludismepublished 2012The American journal of tropical medicine and hygieneeurope_pmcdocument of 5 observations
99 %Sulfadoxine-pyrimethamine has >99% efficacy in treating uncomplicated malaria in Mali.
Malipaludismepublished 2002The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observationsDOI 10.4269/ajtmh.2002.67.604
96.9 %The proportion of triple dhfr mutants was 96.9% in 2021.
Malipaludismeobserved 2021published 2025Malaria journaleurope_pmcdocument of 5 observations
17.21 %Children aged 1–4 years accounted for 17.21% of reported malaria cases in the Kidal region from May 2024 to February 2025.
Malipaludismeobserved May 2024 to February 2025HAL · Unilimdocument of 80 observations
98.9 %SickleScan® had a negative predictive value of 98.90% to detect sickle cell disease carrier compared to high-performance liquid chromatography.
MalidrépanocytoseHAL · Unilimdocument of 103 observations
1 per_100Au Mali, le Centre de Recherche et de Lutte contre la Drépanocytose a réduit le taux de mortalité des enfants drépanocytaires de moins de 5 ans sous suivi médical à moins de 1 %.
MalidrépanocytoseHAL · Unilimdocument of 857 observations
22.4 %La proportion de porteurs asymptomatiques du parasite était de 22,4 % dans la localité étudiée.
MalipaludismeHAL · Unilimdocument of 214 observations
41.8 msChez les patients hétérozygotes A/G pour le variant rs1805121, la médiane de ΔQTc était de 41,8 ms (IC à 95 % : 11–83 ms), avec une différence statistiquement significative (P = 0,019).
Malirs1805121HAL · Unilimdocument of 62 observations
88 msUn patient hétérozygote pour la variante NM_000238.4:c.2118C > T a présenté des prolongations très élevées de l'intervalle QTc de 88 ms, 74 ms et 16 ms lors de trois épisodes.
Maliprolongation de l'intervalle QTcHAL · Unilimdocument of 62 observations
20 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Malawi était de 20 % en 2014.
MaliVIH/sidaobserved 2014HAL · Unilimdocument of 747 observations
44 %Une chimio-prévention SP-AQ à raison d'une dose de SP pour 3 doses journalières de AQ par mois pendant la saison de forte transmission réduisait de 44 % le risque d'avoir un test rapide de diagnostic positif pour le paludisme chez les enfants de moins de 5 ans.
MalipaludismeHAL · Unilimdocument of 113 observations
Individuals with sickle cell trait had significantly lower antibody levels to all blood-stage antigens.
Malipaludismepublished 2015Malaria journaleurope_pmcdocument of 3 observations
70.6 %The protective efficacy of the combination as compared with the vaccine alone was 70.6% against hospital admission with severe malaria according to the World Health Organization definition.
Malipaludismepublished 2021The New England journal of medicineeurope_pmcdocument of 10 observations
36 %Over a 16-month period, 107 (36%) children experienced at least one malaria attack.
Malipaludismeobserved 16-month periodpublished 2021Gut Microbiota Influences Plasmodium Falciparum Malaria Susceptibilityeurope_pmcdocument of 2 observationsDOI 10.20944/preprints202105.0710.v1
3,327 Community Health WorkersAs of 2023, there were about 3,327 Community Health Workers who diagnosed 8% of the total malaria cases.
Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations
71.1 %In COVID-19 patients (n = 266), 71.1% responded to the RBD antigen.
MaliCOVID-19HAL · Unilimdocument of 67 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.